Cargando…

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice

Bile acids facilitate the intestinal absorption of dietary lipids and act as signalling molecules in the maintenance of metabolic homeostasis. Farnesoid X receptor (FXR) is a bile acid-responsive nuclear receptor involved in bile acid metabolism, as well as lipid and glucose homeostasis. Several stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jiufang, van Dijk, Theo H., Koehorst, Martijn, Havinga, Rick, de Boer, Jan Freark, Kuipers, Folkert, van Zutphen, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961586/ https://www.ncbi.nlm.nih.gov/pubmed/36835544 http://dx.doi.org/10.3390/ijms24044132

Ejemplares similares

Hepatic Farnesoid X-Receptor Isoforms α2 and α4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice
por: Boesjes, Marije, et al.
Publicado: (2014)

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70(−/−) Mice with a Human-like Bile Acid Composition
por: Palmiotti, Anna, et al.
Publicado: (2023)

Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70(-/-) mice with human-like bile acids
por: de Vries, Hilde D., et al.
Publicado: (2022)

Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
por: Meissner, Maxi, et al.
Publicado: (2011)

Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
por: Prawitt, Janne, et al.
Publicado: (2011)

A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70(−/−) mice by reducing fat absorption
por: Li, Rumei, et al.
Publicado: (2021)

High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice
por: Oosterveer, Maaike H., et al.
Publicado: (2009)

Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition
por: Verkade, Esther, et al.
Publicado: (2023)

The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis
por: Heida, Andries, et al.
Publicado: (2021)

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
por: Zhang, Boyan, et al.
Publicado: (2021)

Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway
por: Cheng, Zhi-Qiang, et al.
Publicado: (2022)

Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice
por: Hoogerland, Joanne A., et al.
Publicado: (2019)

A novel role for farnesoid X receptor in the bile acid‐mediated intestinal glucose homeostasis
por: Zhao, Long, et al.
Publicado: (2020)

Effects of an early life diet containing large phospholipid-coated lipid globules on hepatic lipid metabolism in mice
por: Ronda, Onne A. H. O., et al.
Publicado: (2020)

Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor
por: Tveter, Kevin M, et al.
Publicado: (2020)

INTESTINAL OBSTRUCTION : IV. THE MECHANISM OF ABSORPTION FROM THE MUCOSA OF CLOSED DUODENAL LOOPS.
por: Whipple, G. H., et al.
Publicado: (1914)

Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH
por: Ronda, Onne A.H.O., et al.
Publicado: (2022)

Impaired Hepatic Phosphatidylcholine Synthesis Leads to Cholestasis in Mice Challenged With a High‐Fat Diet
por: Wan, Sereana, et al.
Publicado: (2019)

Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β
por: van de Wiel, Sandra M.W., et al.
Publicado: (2017)

Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice
por: Ikpa, Pauline T., et al.
Publicado: (2019)

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
por: Zhou, Enchen, et al.
Publicado: (2020)

Evidence of glucose absorption in a neoformed intestine
por: Tuveri, Massimiliano, et al.
Publicado: (2022)

Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats
por: Ceulemans, Laurens J., et al.
Publicado: (2017)

MITOCHONDRIAL CHANGES INDUCED BY IRON ABSORPTION IN THE DUODENAL ABSORPTIVE CELLS OF RATS
por: Oki, Keiichi, et al.
Publicado: (1965)

Regulation of Intestinal Glucose Absorption by Ion Channels and Transporters
por: Chen, Lihong, et al.
Publicado: (2016)

Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet
por: Ronda, Onne A. H. O., et al.
Publicado: (2020)

Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
por: Doktorova, Marcela, et al.
Publicado: (2017)

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
por: Jiang, Changtao, et al.
Publicado: (2015)

Enhanced Alcoholic Liver Disease in Mice with Intestine-specific Farnesoid X Receptor Deficiency
por: Huang, Mingxing, et al.
Publicado: (2020)

Identification of FDA-approved drugs targeting the Farnesoid X Receptor
por: van de Wiel, Sandra M. W., et al.
Publicado: (2019)

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption
por: Powell, David R, et al.
Publicado: (2019)

Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function
por: Oosterveer, Maaike H, et al.
Publicado: (2011)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

Intestinal absorption of glucose in mice as determined by positron emission tomography
por: Sala‐Rabanal, Monica, et al.
Publicado: (2018)

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020)

OR22-5 Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption
por: Powell, David, et al.
Publicado: (2019)

Berberine Decreases Intestinal GLUT2 Translocation and Reduces Intestinal Glucose Absorption in Mice
por: Zhang, Min, et al.
Publicado: (2021)

Systems genetics approach reveals cross-talk between bile acids and intestinal microbes
por: Fu, Jingyuan, et al.
Publicado: (2019)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
por: Qiu, Yuxiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5ipb4vnuu81ejhcoc1ehkeeg9